Last updated on October 2015

Safety & Efficacy of Pegolsihematide for Treatment of Anemia in Participants on Dialysis


Brief description of study

The purpose of this study is to evaluate the safety and efficacy of multiple intravenous doses of pegol-Sihematide in participants with chronic kidney disease (CKD) who are on dialysis.

Clinical Study Identifier: NCT02586402

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Changlin Mei

Changzheng Hospital
Shanghai, China
  Connect »